Especially, similar aberrant insulin signaling between the brains of AD and DM patients supports the idea that AD can be considered “type III DM” [45,46,47,48], and the histopathological evidence confirms this [49,50,51,52,53]. This evidence concerns the gene INS and Alzheimer disease.